BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 3489516)

  • 1. Characterization of variant and parental-cross-protective immunity to immunogenic variants of a murine fibrosarcoma using the local adoptive transfer assay.
    Simcik W; Sheu TL; LeGrue SJ
    Cancer Immunol Immunother; 1989; 30(4):219-26. PubMed ID: 2598191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of in vivo and in vitro effectivity of immune defense against a spontaneously arising, nonlymphoid rat tumor. II. T cell response after induction of immunogenicity.
    Zöller M
    Cancer Immunol Immunother; 1985; 19(3):189-97. PubMed ID: 2408743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of generation of concomitant antitumor immunity by passively transferred suppressor T cells from tumor-bearing donors.
    Bursuker I; North RJ
    Cancer Immunol Immunother; 1985; 19(3):215-8. PubMed ID: 3159472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma-irradiation facilitates the expression of adoptive immunity against established tumors by eliminating suppressor T cells.
    North RJ
    Cancer Immunol Immunother; 1984; 16(3):175-81. PubMed ID: 6231095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of immunoprotective tumor antigens by preparative isotachophoresis.
    Saunders TL; Kahan BD; Pellis NR
    Cancer Immunol Immunother; 1983; 16(2):101-8. PubMed ID: 6559101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary restriction reduces the incidence of 3-methylcholanthrene-induced tumors in mice: close correlation with its potentiating effect on host T cell functions.
    Konno A; Hishinuma K; Hashimoto Y; Kimura S; Nishimura T
    Cancer Immunol Immunother; 1991; 33(5):293-8. PubMed ID: 1868487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of highly immunogenic variants of a rat fibrosarcoma line during in vitro cultivation.
    Yamashina K; Oikawa T; Kasai M; Naiki M; Chiba I; Kobayashi H
    Cancer Immunol Immunother; 1986; 21(1):45-50. PubMed ID: 3632916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of immune status of host on immunogenicity of tumors induced with two doses of methylcholanthrene.
    Lawler EM; Prehn RT
    Cancer Immunol Immunother; 1982; 13(3):194-7. PubMed ID: 6762248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of purification on the immunogenicity of tumor-specific transplantation antigens.
    Saunders TL; Kahan BD; Pellis NR
    Cancer Immunol Immunother; 1985; 19(1):22-7. PubMed ID: 3844971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using methylcholanthrene-induced fibrosarcomas to study tumor immunology.
    Lauder SN; Milutinovic S; Pires A; Smart K; Godkin A; Gallimore A
    Methods Cell Biol; 2021; 163():59-75. PubMed ID: 33785169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of specific adoptive immunotherapy owing to survival and outgrowth of variant cells.
    Hines DL
    Cancer Immunol Immunother; 1989; 28(4):241-7. PubMed ID: 2495177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour-induced immunity to H-Y-disparate skin grafts without concomitant priming of CTL.
    Johnson LL; Hines DL
    Immunology; 1990 Jan; 69(1):85-90. PubMed ID: 2312158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of antigens on UV radiation-induced antigenic tumor cell variants measured in vitro and in vivo.
    Hostetler LW; Romerdahl CA; Kripke ML
    Cancer Res; 1989 Mar; 49(5):1207-13. PubMed ID: 2465081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of H-2 antigens and inducibility of antitumor immune responses in various tumor cell clones established from methylcholanthrene-induced fibrosarcomas.
    Ogata M; Shimizu J; Kosaka H; Maekawa R; Shimizu K; Fujiwara H; Hamaoka T
    Jpn J Cancer Res; 1986 Nov; 77(11):1134-41. PubMed ID: 3098723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of antigenic variants from a nonantigenic murine tumor cell line by transfection with a gene encoding a novel tumor-specific transplantation antigen.
    Kaba DS; McIntyre BW; Kripke ML; Goodenow RS; Schreiber H; Ananthaswamy HN
    Cancer Res; 1989 Jan; 49(1):38-43. PubMed ID: 2783244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-specific transplantation antigens of chemically induced tumors.
    Lennox ES; Sikora K
    Adv Pathobiol; 1977; (6):68-78. PubMed ID: 70987
    [No Abstract]   [Full Text] [Related]  

  • 17. [Relationship between tumor antigens and histocompatibility antigens at the cell membrane].
    Meyer G; Berebbi M; Oth D
    Bull Cancer; 1976; 63(1):111-21. PubMed ID: 791395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of tumor-associated transplantation antigens of sublines of methylcholanthrene-induced murine tumors passaged separately in vivo for over a decade.
    Hines DL
    Cancer Res; 1986 Oct; 46(10):4921-6. PubMed ID: 3489516
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.